WO2009110577A1 - 免疫学的測定法、キット及び展開溶媒 - Google Patents
免疫学的測定法、キット及び展開溶媒 Download PDFInfo
- Publication number
- WO2009110577A1 WO2009110577A1 PCT/JP2009/054230 JP2009054230W WO2009110577A1 WO 2009110577 A1 WO2009110577 A1 WO 2009110577A1 JP 2009054230 W JP2009054230 W JP 2009054230W WO 2009110577 A1 WO2009110577 A1 WO 2009110577A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- substance
- antibody
- antigen
- detected
- immobilized
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
Definitions
- the present invention relates to an immunological assay, an immunological assay kit, an immunochromatographic test strip and a developing solvent used therefor.
- Japanese Patent Application Laid-Open No. 2 0 06 _ 1 7 7 9 70 describes that the cell separation structure of the porous separation matrix of the immunochromatographic test piece is characterized, Alternatively, it is disclosed that the porous separation matrix is impregnated with mannitol.
- Mannitol impregnated in a porous separation matrix is known to have an effect of preventing red blood cell hemolysis, for example, as used as a component of MAP solution.
- an immunoassay When used at a sufficient concentration, the detection time of the detected substance becomes longer and a new problem occurs when non-specific reactions are likely to occur. Disclosure of the invention
- an object of the present invention is to provide an immunological measurement method capable of suppressing a nonspecific reaction with a short detection time. Another object of the present invention is to suppress a nonspecific reaction in a short detection time while preventing a hemolysis reaction by allowing a substance to be detected in blood to coexist with mannitol and a surfactant in a measurement system. It is to provide an immunological assay that can be detected by the above method.
- Still another object of the present invention is to provide a kit for the above measurement method, a test piece for immunochromatography and a developing solvent.
- a method for immunologically measuring a substance to be detected using an immunochromatographic test strip comprising an insoluble carrier to which a second antibody or second antigen is immobilized and a porous separation matrix capable of cell separation.
- the porous separation matrix is preliminarily infiltrated with a surfactant, and the insoluble carrier specifically bound to the detected substance via the second antibody or the second antigen is developed with a developing solvent containing mannitol.
- the above-mentioned objects and advantages of the present invention are as follows.
- a method for immunologically measuring the substance to be detected using an immunochromatographic test strip comprising an insoluble carrier on which a second antibody or second antigen is immobilized and a porous separation matrix capable of cell separation,
- the insoluble carrier specifically bound to the substance to be detected and the second antibody or second antigen is developed with a developing solvent containing both mannitol and a surfactant. Achieved by immunoassay method.
- the above-mentioned objects and advantages of the present invention are as follows.
- the first antibody or the first antigen that specifically binds to the substance to be detected or the membrane carrier on which the first antigen is immobilized specifically binds to the substance to be detected.
- an immunochromatographic test strip comprising an insoluble carrier to which the second antibody or second antigen is immobilized and a porous separation matrix capable of cell separation
- the porous separation matrix is preliminarily infiltrated with a surfactant, and the detected substance and the second antibody or the second antigen It is achieved by an immunological measurement method characterized by developing the insoluble carrier specifically bound via a developing solvent with a developing solvent containing both mannitol and a surfactant.
- the first antibody or the first antigen that specifically binds to the substance to be detected or the membrane carrier on which the first antigen is immobilized specifically binds to the substance to be detected.
- a test piece for immunochromatography comprising a porous separation matrix capable of cell separation, infiltrated with an insoluble carrier and a surfactant to which a second antibody or second antigen is immobilized, and the detected substance and the second Achieved by an immunoassay kit characterized by comprising a combination of a development medium containing mannitol for developing the insoluble carrier specifically bound via an antibody or a second antigen.
- An immunochromatographic test strip comprising an insoluble carrier on which the second antibody or second antigen is immobilized and a porous separation matrix capable of cell separation, and the detected substance and the second antibody or second antigen It is achieved by an immunoassay kit comprising a combination of developing solvents containing both mannitol and a surfactant for developing the specifically bound insoluble carrier.
- an immunoassay kit comprising a combination of developing solvents containing both mannitol and a surfactant for developing the specifically bound insoluble carrier.
- the first antibody or the first antigen that specifically binds to the detected substance or the membrane carrier on which the first antigen is immobilized specifically binds to the detected substance
- a test piece for immunochromatography comprising a porous separation matrix capable of cell separation, infiltrated with an insoluble carrier and a surfactant to which a second antibody or second antigen is immobilized, and the detected substance and the second
- An immunoassay comprising a combination of a developing solvent containing both mannitol and a surfactant for developing the insoluble carrier specifically bound via an antibody or a second antigen. Achieved by kite.
- FIG. 1 is a schematic diagram of a test piece for immunochromatography. BEST MODE FOR CARRYING OUT THE INVENTION
- any surfactant can be used as long as it is used for biochemistry.
- Preferred is a surfactant having an HLB of 8 to 20, and more preferred is a nonionic surfactant having an HLB of 8 to 20.
- Tr it on X—100 (trade name): Polyethylene glycol mono-p— ⁇ ⁇ Noctylphenol monotel, Twe en 20: Polyoxyethylene sorbitan monolaurate, Twe en 80: Polyoxyethylene sorbitol No nidet P— 40: Nonidet P — 40, ZWI TTERGENT 3— 14: n—Tetradecyl N, N—Dimethyl— 3—Ammonio 1 _Propanesulfonate, CHAPS: 3— [(3— Collamidopropyl ) Dimethylammonio] propanesulfonic acid, sodium dodecyl sulfate (SDS), and the like.
- These surfactants can be used alone or in admixture of two or more.
- a specimen sample of the detected substance to be examined is dropped on the material addition site 1 in Fig. 1.
- Sample addition site 1 consists of an immunochromatographic test strip consisting of a porous separation matrix capable of cell separation.
- the porous separation matrix is preferably infiltrated with a surfactant in advance before the sample is dropped.
- the method of infiltrating the porous separation matrix with the surfactant is not particularly limited.
- the matrix is added to the surfactant solution. Examples include a method of heat drying after immersing the trix.
- the specimen to be used in the present invention is not particularly limited as long as it contains cells and blood cells, and examples thereof include blood, urine, and cerebrospinal fluid.
- substances to be detected from specimens include virus surface antigens such as HBs antigen, tumor markers such as PSA, CEA, and AFP, anti-HIV antibodies, anti-HBV antibodies, anti-HCV antibodies, anti-mite allergen antibodies, anti-antigens
- virus surface antigens such as HBs antigen
- tumor markers such as PSA, CEA, and AFP
- anti-HIV antibodies anti-HBV antibodies
- anti-HCV antibodies anti-mite allergen antibodies
- anti-antigens examples include, but are not limited to, immunoglobulins such as cedar pollen allergen antibodies.
- the sample dropped on the sample addition site 1 is a labeled substance holding site on which an insoluble carrier on which an antibody or antigen (specifically referred to as a second antibody or a second antigen) that specifically binds to the substance to be detected is fixed is held.
- the sample is developed in the direction of the absorption site 5 via the mouthmatography medium 3 after 2.
- An antibody or antigen (specifically referred to as the first antibody and the first antigen, respectively) that specifically binds to the substance to be detected is immobilized at the detection site 4.
- the carrier for developing the substance to be detected by the chromatography medium 3 and having the detection site 4 is composed of a membrane carrier.
- a developing solvent containing mannitol is used as the chromatography medium.
- Mannitol is preferably contained in the developing solvent in a proportion of 1 to 15% by weight.
- the target substance to be detected When the target substance to be detected is mixed in the sample, the target substance reacts with the second antibody or the second antigen, and these complexes react with the first antigen or the first antibody at the detection site 4. A colored band appears. The amount of the substance to be detected contained in the sample can be roughly grasped by the color tone of the band appearing in FIG.
- the second antigen or second antibody used for the labeling substance holding site 2 and the first antigen or first antibody used for the detection site 4 may be those that bind different sites of the substance to be detected.
- an antibody that specifically binds to the substance to be detected is used. Antibodies include humans, mice, rats, rabbits, goats, horses, etc. as their production animal species, and each has a specific range of immunoglobulins.
- IgG, IgM, IgA, IgE and IgD may be used, and monoclonal antibodies, polyclonal antibodies, and fragments thereof (having antigen-binding ability; for example, H chain, L chain, Fab) , F (ab ′) 2, etc. may be used.
- an anti-PSA antibody an anti-AFP antibody, an anti-CEA antibody, an anti-HBs antibody, an anti-IgG antibody, an anti-human IgE antibody, etc., and these fragments (which have an antigen-binding ability; F (ab) '2 or Fab, etc.
- an antigen that specifically binds to the substance to be detected is used.
- HBs antigen, HCV antigen, mite allergen, cedar pollen allergen and the like can be mentioned.
- examples of insoluble carriers for labeling antigens and antibodies include metal colloid particles such as gold colloid particles, non-metal colloid particles such as selenium colloid particles, colored resin particles such as latex particles, dye colloid particles, and colored ribosomes.
- examples of insoluble particulate substances include insoluble particulate substances.
- enzymes that label antigens and antibodies include peroxidase, alkaline phosphatase, and glucose oxidase.
- the membrane carrier for the chromatography medium is not particularly limited as long as it can absorb and flow the sample specimen by capillary action.
- the immunochromatographic test piece used in the method of the present invention preferably has a porous separation matrix preliminarily infiltrated with a surfactant, more preferably a surfactant with HLB of 8 to 20. It has the characteristics. Based on such characteristics, according to the present invention, the first antibody or the first antigen that specifically binds to the substance to be detected is immobilized on the membrane carrier, the second antibody or the second antigen that specifically binds to the substance to be detected. Porous separator that is infiltrated with an insoluble carrier and a surfactant that can be separated An immunochromatographic test strip comprising Tricks is provided.
- a developing solvent containing the immunochromatographic test strip of the present invention and mannitol preferably at a concentration of 1 to 15% by weight.
- An immunological measurement kit consisting of a combination of these is also provided.
- the kit for carrying out the method of the present invention is similarly provided with a preferable range of a developing solvent containing a surfactant and mannitol used in the immunological assay.
- a sheet made of nitrocellulose (manufactured by Millipore, trade name: HF 120, 30 OmmX 2 ⁇ mm) was used as a membrane carrier (membrene).
- PSA mouse-derived anti-prostate cancer-specific antigen
- Gold colloid dispersion manufactured by Tanaka Kikinzoku Kogyo Co., Ltd .: LC 40 nm
- Mouse-derived anti-PSA diluted to 0.5 ml in phosphate buffer (pH 7.4) to a concentration of 0.1 mgZm 1
- Monoclonal antibody (second antibody) was added in an amount of 0.1 mL and allowed to stand at room temperature for 10 minutes.
- BSA bovine serum albumin
- the labeling substance solution was prepared by the above procedure.
- the chromatography medium prepared above, the labeling substance holding member, the sample pad used for the part to which the sample is added, and the absorbent pad for absorbing the developed sample and labeling substance are pasted on the base material made of the backing sheet. Combined. And it cut
- HE PES buffer solution pH 8.0
- 1 wt% BSA and 15 OmM NaC1 plus D-mannitol manufactured by Wako Pure Chemical Industries, Ltd.
- 10 wt% Prepared and used as a solvent for development.
- the presence or absence of PSA in blood was measured by the following method.
- a negative sample with a PSA concentration in blood of less than 0.1 ngZmL and a positive sample with a PSA concentration of 4 ng / mL are used as samples, and sample 2 is placed on the sample pad of an immunochromatography test strip.
- 100 At L developing solvent was placed on a sample pad and developed, and visually judged after 15 minutes. “+” Indicates that the red line on the test line can be confirmed, “red” indicates that the red line can be confirmed, “Sat” indicates that the color is very light, “one” indicates that the red line cannot be confirmed, and indicates that the test line cannot be measured due to hemolysis “No judgment”. The results are shown in Table 1. Table 2 shows the presence or absence of hemolysis.
- Example 2 shows the presence or absence of hemolysis.
- Example 2 shows the presence or absence of hemolysis.
- Example 2 shows the presence or absence of hemolysis.
- Example 2 shows the presence or absence of hemolysis.
- Example 6 except that the sample pad does not absorb the surfactant. Similar results were obtained when measurements were taken in the same manner as in Example 6.
- Example 2 shows the presence or absence of hemolysis.
- Example 1 The antibody applied to the membrane in Example 1 was changed to the mouse-derived anti-carcinoembryonic antigen (CEA) monoclonal antibody (first antibody), and the antibody immobilized on the gold colloid was changed to the mouse-derived anti-CE A monoclonal antibody (second antibody).
- CEA mouse-derived anti-carcinoembryonic antigen
- second antibody mouse-derived anti-CE A monoclonal antibody
- the sample used for the measurement was measured in the same manner as in Example 1 except that the negative sample was blood with a CEA concentration of less than 1 ngZmL, and the positive sample was blood with a CEA concentration of 10 ngZmL. Went.
- Table 3 The results are shown in Table 3, including the presence or absence of hemolysis. Table 3
- an immunoassay method that enables detection of a substance to be detected in a short time and enables accurate detection by suppressing a non-specific reaction, and kit and development therefor.
- a solvent can be provided.
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/921,356 US20110003320A1 (en) | 2008-03-06 | 2009-02-27 | Immunoassay method and kit and developing solvent therefor |
EP09717905.5A EP2251690B1 (en) | 2008-03-06 | 2009-02-27 | Immunoassay method and kit |
CN2009801027263A CN101952722A (zh) | 2008-03-06 | 2009-02-27 | 免疫学测定法、试剂盒及展开溶剂 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008056180A JP4428670B2 (ja) | 2008-03-06 | 2008-03-06 | 免疫学的測定法、キット及び展開溶媒 |
JP2008-056180 | 2008-03-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009110577A1 true WO2009110577A1 (ja) | 2009-09-11 |
Family
ID=41056129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2009/054230 WO2009110577A1 (ja) | 2008-03-06 | 2009-02-27 | 免疫学的測定法、キット及び展開溶媒 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20110003320A1 (ja) |
EP (1) | EP2251690B1 (ja) |
JP (1) | JP4428670B2 (ja) |
CN (1) | CN101952722A (ja) |
WO (1) | WO2009110577A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102713625A (zh) * | 2010-01-08 | 2012-10-03 | 田中贵金属工业株式会社 | 免疫层析用试剂组合物 |
CN103052884A (zh) * | 2010-08-03 | 2013-04-17 | 田中贵金属工业株式会社 | 免疫层析用试剂组合物以及使用该组合物的测定方法 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4559510B2 (ja) * | 2008-07-14 | 2010-10-06 | 田中貴金属工業株式会社 | イムノクロマトグラフ法のための展開液、及びそれを用いた測定方法 |
CN102770751A (zh) * | 2010-02-23 | 2012-11-07 | B.R.A.H.M.S有限公司 | 测定小体积体液样品中的标志物的方法 |
JP5822239B2 (ja) | 2010-12-08 | 2015-11-24 | 公立大学法人大阪府立大学 | 金属ナノ粒子集積構造体を利用した被検出物質の検出装置および方法 |
WO2013147307A1 (ja) * | 2012-03-30 | 2013-10-03 | 積水メディカル株式会社 | 赤血球含有サンプル中の対象物を検出するためのイムノクロマトグラフィー用テストストリップおよびイムノクロマトグラフィーを利用した検出方法 |
JP5723484B2 (ja) | 2012-03-30 | 2015-05-27 | 積水メディカル株式会社 | 赤血球含有サンプル中の対象物を検出するためのイムノクロマトグラフィー用テストストリップおよびイムノクロマトグラフィーを利用した検出方法 |
JP6099108B2 (ja) | 2013-05-30 | 2017-03-29 | 公立大学法人大阪府立大学 | 被検出物質の検出装置および方法 |
JP5767362B1 (ja) * | 2014-04-25 | 2015-08-19 | 田中貴金属工業株式会社 | 免疫クロマト分析装置、免疫クロマト分析方法及び免疫クロマト分析キット |
JP6397224B2 (ja) * | 2014-06-04 | 2018-09-26 | 田中貴金属工業株式会社 | 免疫学的測定試薬におけるプロゾーン現象の解消法 |
JP6452491B2 (ja) * | 2015-02-27 | 2019-01-16 | デンカ生研株式会社 | イムノクロマト法検査デバイスの試料添加部の形成方法及びイムノクロマト法検査デバイス |
CN109324184A (zh) * | 2018-12-05 | 2019-02-12 | 厦门同仁心生物技术有限公司 | 一种丙型肝炎病毒抗原荧光免疫层析检测试剂盒及其制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07325085A (ja) * | 1994-05-30 | 1995-12-12 | Teikoku Hormone Mfg Co Ltd | イムノクロマト法によるハプテンの半定量方法および装置 |
JPH11153600A (ja) * | 1997-11-21 | 1999-06-08 | Fujirebio Inc | 免疫測定用試験片及び該試験片を用いる測定法 |
JP2001289852A (ja) * | 2000-04-06 | 2001-10-19 | Wakamoto Pharmaceut Co Ltd | イムノクロマトグラフィー装置 |
JP2002148266A (ja) * | 2000-11-10 | 2002-05-22 | Rohto Pharmaceut Co Ltd | 検出装置及びその製造方法 |
JP2006177970A (ja) | 1995-05-09 | 2006-07-06 | Beckman Coulter Inc | 血液の液体部分から血液の細胞成分を分離する装置および方法 |
JP2007524813A (ja) * | 2003-06-06 | 2007-08-30 | アドバンテイジ ダイアグノスティックス コーポレイション | サンプル中の分析物についての診断試験 |
JP2007322310A (ja) * | 2006-06-02 | 2007-12-13 | Nippon Kayaku Co Ltd | 検体中の分析対象物質の検出あるいは測定方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5514602A (en) * | 1986-06-09 | 1996-05-07 | Ortho Diagnostic Systems, Inc. | Method of producing a metal sol reagent containing colloidal metal particles |
US5714340A (en) * | 1992-12-22 | 1998-02-03 | Johnson & Johnson Clinical Diagnostics, Inc. | Immunoassay elements having a receptor zone |
US5372932A (en) * | 1992-12-22 | 1994-12-13 | Eastman Kodak Company | Analytical element and method for the determination of a specific binding ligand using a 4-hydroxy or 4-alkoxyarylacetamide as stabilizer |
US6852289B2 (en) * | 1996-10-02 | 2005-02-08 | Saftest, Inc. | Methods and apparatus for determining analytes in various matrices |
US5879951A (en) * | 1997-01-29 | 1999-03-09 | Smithkline Diagnostics, Inc. | Opposable-element assay device employing unidirectional flow |
US6528323B1 (en) * | 1999-06-14 | 2003-03-04 | Praxsys Biosystems, Inc. | Bidirectional lateral flow test strip and method |
NL1027737C2 (nl) * | 2004-12-14 | 2006-06-16 | Teststrip B V | Chromatografische analyse-inrichting en test kit. |
KR101255400B1 (ko) * | 2005-05-23 | 2013-04-17 | 파디아 에이비 | 2 단계 횡 유동 검사 방법 및 장치 |
US20080138842A1 (en) * | 2006-12-11 | 2008-06-12 | Hans Boehringer | Indirect lateral flow sandwich assay |
-
2008
- 2008-03-06 JP JP2008056180A patent/JP4428670B2/ja active Active
-
2009
- 2009-02-27 EP EP09717905.5A patent/EP2251690B1/en not_active Not-in-force
- 2009-02-27 US US12/921,356 patent/US20110003320A1/en not_active Abandoned
- 2009-02-27 CN CN2009801027263A patent/CN101952722A/zh active Pending
- 2009-02-27 WO PCT/JP2009/054230 patent/WO2009110577A1/ja active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07325085A (ja) * | 1994-05-30 | 1995-12-12 | Teikoku Hormone Mfg Co Ltd | イムノクロマト法によるハプテンの半定量方法および装置 |
JP2006177970A (ja) | 1995-05-09 | 2006-07-06 | Beckman Coulter Inc | 血液の液体部分から血液の細胞成分を分離する装置および方法 |
JPH11153600A (ja) * | 1997-11-21 | 1999-06-08 | Fujirebio Inc | 免疫測定用試験片及び該試験片を用いる測定法 |
JP2001289852A (ja) * | 2000-04-06 | 2001-10-19 | Wakamoto Pharmaceut Co Ltd | イムノクロマトグラフィー装置 |
JP2002148266A (ja) * | 2000-11-10 | 2002-05-22 | Rohto Pharmaceut Co Ltd | 検出装置及びその製造方法 |
JP2007524813A (ja) * | 2003-06-06 | 2007-08-30 | アドバンテイジ ダイアグノスティックス コーポレイション | サンプル中の分析物についての診断試験 |
JP2007322310A (ja) * | 2006-06-02 | 2007-12-13 | Nippon Kayaku Co Ltd | 検体中の分析対象物質の検出あるいは測定方法 |
Non-Patent Citations (1)
Title |
---|
See also references of EP2251690A4 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102713625A (zh) * | 2010-01-08 | 2012-10-03 | 田中贵金属工业株式会社 | 免疫层析用试剂组合物 |
CN103052884A (zh) * | 2010-08-03 | 2013-04-17 | 田中贵金属工业株式会社 | 免疫层析用试剂组合物以及使用该组合物的测定方法 |
CN103052884B (zh) * | 2010-08-03 | 2015-07-15 | 田中贵金属工业株式会社 | 免疫层析用试剂组合物以及使用该组合物的测定方法 |
US9952207B2 (en) | 2010-08-03 | 2018-04-24 | Tanaka Kikinzoku Kogyo K.K. | Immunochromatography reagent comprising a nonionic surfactant, bicine, and casein, and measurement method using the same |
Also Published As
Publication number | Publication date |
---|---|
JP2009210505A (ja) | 2009-09-17 |
US20110003320A1 (en) | 2011-01-06 |
EP2251690A1 (en) | 2010-11-17 |
CN101952722A (zh) | 2011-01-19 |
JP4428670B2 (ja) | 2010-03-10 |
EP2251690A4 (en) | 2011-04-27 |
EP2251690B1 (en) | 2016-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4428670B2 (ja) | 免疫学的測定法、キット及び展開溶媒 | |
JP6008670B2 (ja) | イムノクロマトグラフ試験ストリップ用メンブレン、試験ストリップ及び検査方法 | |
US10591470B2 (en) | Immunochromatographic analysis method | |
JP2007322310A (ja) | 検体中の分析対象物質の検出あるいは測定方法 | |
EP2506013B1 (en) | Highly sensitive immunochromatography method | |
JP4382866B1 (ja) | クロマトグラフ媒体 | |
CN107430120B (zh) | 免疫检测方法和用于其的测试条 | |
KR102586991B1 (ko) | 면역크로마토그래피 장치 | |
WO2015163384A1 (ja) | 免疫クロマト分析装置、免疫クロマト分析方法及び免疫クロマト分析キット | |
WO2009099240A1 (ja) | 免疫学的測定用の検体処理試薬組成物 | |
JP6270781B2 (ja) | クロマト分析装置およびクロマト分析方法 | |
JP4437211B2 (ja) | 免疫クロマトグラフィーを用いた測定方法およびそれに用いる検体分析用具 | |
JP4932765B2 (ja) | 免疫クロマトグラフィー用展開溶媒 | |
JP4544907B2 (ja) | デバイスおよび検出方法 | |
JP5714791B2 (ja) | 非特異反応抑制剤 | |
JP2010060297A (ja) | 免疫分析方法およびそれに用いる検体分析用具 | |
JP6470147B2 (ja) | 免疫学的検出方法 | |
JP6595215B2 (ja) | 免疫クロマト分析装置およびその製造方法並びに免疫クロマト分析方法 | |
WO2022265105A1 (ja) | イムノクロマト試験片およびイムノクロマトキット | |
WO2021193792A1 (ja) | イムノクロマトグラフキットおよびイムノクロマトグラフ方法 | |
JP2009133740A (ja) | イムノクロマトグラフィー用試験片 | |
JP2009133739A (ja) | イムノクロマトグラフィー用試験キット | |
WO2011152098A1 (ja) | イムノクロマトグラフ法のための展開液およびそれを用いた測定法 | |
JP2001330610A (ja) | 免疫学的検出方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980102726.3 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09717905 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 5560/CHENP/2010 Country of ref document: IN Ref document number: 2009717905 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12921356 Country of ref document: US |